by a processing fragment (P) from the yeast killer preprotoxin containing a C-terminal lysine-arginine site for cleavage by the Golgi-associated Kex2 protease. Ste2 is predicted to have a rhodopsinlike topology, with an external N terminus and seven transmembrane segments. Fusions to three of the four Ste2 domains predicted to be external resulted in ,la secretion from yeast cells. A fusion at a site just preceding the first transmembrane segment was an exception; the product was ceUl associated, indicating that the first 44 residues of Ste2 are insufficient to direct secretion of DIa; translocation of this domain presumably requires the downstream transmembrane segment. Expression of fusions located in two domains predicted to be cytoplasmic failed to result in Pla secretion. Following insertion of the preprotoxin signal peptide (S) between the Ste2 and P components of these cytoplasmic fusions, secretion of (la activity occurred, which is consistent with inversion of the orientation of the Pla reporter. Conversely, insertion of S between Ste2 and P in an external fusion sharply reduced (la secretion. Complementary information about both cytoplasmic and external domains of Ste2 was therefore provided, and most aspects of the predicted topology were confirmed. The steady-state levels of (la detected were low, presumably because of efficient degradation of the fusions in the secretory pathway; levels, however, were easily detectable. This method should be valuable in the analysis of in vivo topologies of both homologous and foreign plasma membrane proteins expressed in yeast cells.
The use of fusions of N-terminal fragments of a target protein to a C-terminal reporter has proved to be one of the more successful in vivo expression techniques for analyzing membrane insertion topologies of transmembrane proteins in Escherichia coli. Its utility was first demonstrated by Manoil and Beckwith (27) , who constructed a series of gene fusions between E. coli Tsr, an integral membrane protein, and the normally secreted enzyme alkaline phosphatase (PhoA); bacteria containing such fusion proteins expressed high levels of alkaline phosphatase activity only if the site of fusion was located in a domain of Tsr predicted to be periplasmic. Fusions located in putative cytoplasmic domains of Tsr exhibited little or no alkaline phosphatase activity. The gene fusion method has since been used in the topological analysis of several E. coli membrane proteins, and 3-galactosidase (lacZ; 17, 26) has been used as a cytoplasmically active reporter complementary to PhoA. The ,-lactamase product of the bla gene of pBR322 is an especially useful reporter in E. coli, since it is capable of positively identifying both external and cytoplasmic fusion sites (8) . The results are usually interpreted on the basis of the signal/stop-transfer hypothesis of membrane protein insertion (3, 16) . This hypothesis assumes that the twodimensional topology in polytopic transmembrane proteins is determined by the sequential and alternate insertion of each membrane-spanning segment as either a signal peptide (C terminus outside) or a stop-transfer region (C terminus inside) without reference to downstream sequence. The validity of this interpretation is enhanced if both internal and external fusion sites are positively identified and the resulting topological model is internally consistent.
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Although several Saccharomyces cerevisiae membrane proteins have been cloned and their topologies have been predicted from the genomic sequence (11, 12, 19, 29, 34, 36) , only one, 3-hydroxy-3-methylglutaryl coenzyme A reductase, which is located in the endoplasmic reticulum (ER), has so far proved amenable to thorough in vivo topological analysis by gene fusion (33) . Successful applications of gene fusion techniques to topological analysis of yeast plasma membrane proteins have so far been limited to in vivo analysis of the most C-terminal segment of the Ste3 a-factor receptor (12) and in vitro expression systems (1, 20) . Notwithstanding the utility of such studies, a broadly applicable in vivo approach would, in addition to avoiding artifactual problems associated with in vitro systems, be more rapid and flexible. The present paper describes such a system employing a modification of the target-reporter gene fusion technique to allow processing and secretion of the reporter.
Ste2, the product of the STE2 gene, an integral plasma membrane protein that is the receptor for the yeast a-factor mating pheromone, was the target protein chosen for this study. Its predicted topology is homologous to that of the bacteriorhodopsin class of membrane receptors, containing seven clearly predictable transmembrane segments, and it couples to a homologous G protein ( Fig. 1; 9, 29) . The cytoplasmic location of the C-terminal domain of Ste2 is implied by the a-factor-dependent degree of phosphorylation occurring within this domain (31) . The deduced orientation of the N terminus is external (Fig. 1 (S) and an intervening processing region (P) preprotoxin, ppTox (6, 10 (10) . Pla is the mature sequence of P-lactamase preceded by an Asp-Pro-Gly tripeptide (Fig. 2B, i) . The C terminus of T is the Lys Arg-233 site for cleavage by the Kex2 endopeptidase. Cleavage at this site during expression of p20TB results in secretion of ,Bla (10) . p2OSPB (Fig. 2B, i ) is identical to p20TB except that the PstI-to-AccI fragment encompassing codons 35 to 176 of ppTox is deleted and an in-frame PstI linker is inserted, leaving the S (signal) and P (processing) ppTox fragments separated by a single alanine residue (10) . The sequences of S and P are shown in Fig. 2G . Insertion of an XhoI linker at the BstEII site of p20SPB produced the xB fragment in p20SPxB; ila is changed to xpla, and its N terminus is changed to Asp Pro Gly His Asn Ser Ser Cys (Fig. 2B, ii) . The Asn Ser Ser N-glycosylation site was introduced to provide an additional indicator of Pla secretion. Insertion of an NsiI linker at the same BstEII site in p2OSPB produced p2OSPnB (Fig. 2B, iii) . The P-pla fusion is no longer in frame, but insertion of Ste2 fragments in place of P produced direct Ste2-Pla fusions (Fig. 2E) .
Construction of Ste2-nB (direct) and Ste2-PxB fusions. The entire coding sequence of the STE2 gene, as a 1.7-kb HindIII fragment derived from pWS2 (obtained from D. Jenness), was inserted into theHindIll site of the plasmid YEpDT-GAL (24), producing pDTGSte2 (Fig. 2D) Insertion into p2OSPxB (Fig. 2B , ii) gave fusions pSte2-44-PxB, etc. (Fig. 2F ). Each construct was numbered according to the Ste2 codon at the fusion site. Sequences at the fusion sites were determined by using the primer (5') CC GCT GTT GAG ATC CAG, complementary to codons 24 to 29 of mature 13-lactamase. All sequences were as predicted. The position of each Ste2-PxB fusion within the framework of the proposed Ste2 topology and the sequence at each fusion site are shown in Fig. 1 . A variable number of Ala residues derived from the PstI linkers employed were inserted between Ste2 and P. Construction of Ste2-SPB fusions. An XhoI linker (5' CCTCGAGG 3') was inserted into the EcoRl site (blunted with mung bean exonuclease) located at the 3' end of pPGK in p2OSPB (Fig. 2B) . A second linker (PstI; 5' GCTGCAGC 3') was inserted into this XhoI site after filling with the Klenow polymerase I fragment, producing p21SPB ( Fig.  2C ). An open reading frame from this PstI site overlaps the N terminus of the ppTox signal after five codons (Ala Ala Arg Gly Asn MET; Fig. 2G ). The SPB fragment was excised from p21SPB by partial PstI digestion followed by complete digestion with BgIII and was used to replace the (PstI-toBgIII) PxB fragment in plasmids pSte2-98-PxB, pSte2-235-PxB, and pSte2-369-PxB, producing the equivalent pSte2-SPB fusions (Fig. 2G ).
Preparation of cell extracts and assay of I-lactamase activity. Cells were harvested from late-exponential-phase cultures (2 x 107 to 4 x 107 cells per ml) growing in SC-Ura medium buffered with 100 mM NaPO4 (pH 6.8). 3-Lactamase is stabilized in culture supernatants above pH 5.5. Cell extracts were prepared, and 1-lactamase activities in samples (20 ,ul) of culture supernatants and cell extracts were determined by using a microtiter plate assay (10) Chester, Pa.), Ste2-,la fusion proteins were detected by incubation with 125I-labeled protein A (0.1 mCi/ml; NEN Research Products, Boston, Mass.) followed by autoradiography.
RESULTS
Activity of direct Ste2-pla fusions. In transformants of strain DJ213-7-3 expressing pSte2-369-nB, a direct ,la fusion (Fig. 2E) within the presumptively cytoplasmic C terminus of Ste2, we were able to detect cell-associated 13-lactamase activity at a level of 1 to 2 ng/107 cells and a weak signal in Western blots (immunoblots) for a fusion protein of the expected size (data not shown). However, we were unable to detect either activity or immunoreactive protein in cell extracts or membrane preparations from cells of the same strain expressing the equivalent Ste2-98 or Ste2-206 direct fusions. We surmised that any Ste2 fusion lacking parts of its transmembrane segments was being efficiently retained in the ER and destroyed by surveillance systems for aberrant membrane proteins. It also seemed likely that any fraction of the fusion proteins escaping the salvage mechanism and reaching the Golgi was being targeted directly to the vacuole or suffered endocytosis and vacuolar destruction rather than accumulating on the cell surface. We therefore inserted P, containing a C-terminal Kex2 processing site, between the target and reporter in the hope of rescuing the ila reporter component of any fraction of the fusion proteins reaching the Golgi compartment where Kex2 is active (18, 23, 28) . P incorporates codons 177 to 233 of the yeast K1
killer preprotoxin (ppTox; 6, 10) and contains three N-glycosylation sites and a second internal potential Kex2 processing site ( Fig. 2G; 39) . We also inserted an N-glycosylation site at the N terminus of the Pla reporter, changing it to xpla; core N glycosylation of secreted x,la occurs at this site with reasonable efficiency (50 to 60%o); this has no detectable effect on either the efficiency of secretion or the activity or stability of xpla in culture supernatants (10) . The modified fusion constructs are called pSte2-PxB (Fig. 2F ).
Activity and subcellular location of P-lactamase components of Ste2-PxB fusions. We predicted that Ste2-PxB fusions which reach the Golgi anchored to the lumenal face of the membrane by their Ste2 component would be processed to release secreted P-lactamase, while those fusions anchored to the cytoplasmic face would not. This is schematically represented for the Ste2-98-PxB (lumenal) and Ste2-235-PxB (cytoplasmic) fusions in Fig. 3A construct Ste2-98-PxB, Ste2-206-PxB, or Ste2-259-PxB secreted amounts of 13la detectable by activity assay. The site of fusion between Ste2 and PxB in each of these constructs is predicted to be just prior to or within an external loop (Fig.  1) . Transformants containing the three remaining Ste2-PxB fusion protein constructs failed to secrete Pla (Table 1) .
According to the topological model of Ste2, the fusion sites of Ste2-235-PxB and Ste2-369-PxB should be cytoplasmic, while the fusion site of Ste2-44-PxB should be external. However, the N-terminal domain of Ste2 up to Val-48 does not contain a recognizable signal sequence. Translocation of this region of the protein into the lumen of the ER, therefore, is presumably dependent on insertion of at least the first membrane-spanning segment of Ste2 into the ER membrane (15, 16) . In the absence of the first membrane-spanning segment, membrane association and translocation of the Ste2-44-PxB fusion protein would not be predicted, suggesting that this fusion protein should remain cytoplasmic and therefore cell associated, as we found. These results, therefore, are entirely consistent with the topology predicted for Ste2 based on hydropathy analysis and analogy to bacteriorhodopsin ( Fig. 1; 9) .
Effect of an stp22-7 mutation on expression of Ste2--lactamase fusions. Expression of p20SPxB, in which the Ste2 component of the Ste2-PxB fusions is replaced with the ppTox signal (Fig. 2B) , resulted in efficient processing and about 90% secretion of pla at a level 50-fold higher than the highest level seen for any Ste2 fusion ( there is insufficient Ste2 protein in this severely truncated fusion for recognition by the STP22-dependent component of the surveillance mechanism or that because of its structural simplicity, misinsertional or misfolding events involving the Ste2-98-PxB protein are comparatively infrequent. DJ240-8-3 (stp22) transformants containing presumptively cytoplasmic fusion constructs, i.e., Ste2-44-PxB, Ste2-235-PxB, and Ste2-369-PxB, like their STP22 counterparts, failed to secrete detectable amounts of Pla, although a significant increase in cell-associated activity was observed with the last construct ( (14, 23) , probably because of the presence of a similar enzyme encoded by YAP3 (14) . Secreted jla activities of BFY113 transformants of the Ste2-98-PxB fusion were approximately 25% of those of the DJ213-7-3 transformants, and secretion from the 206 and 259 fusions dropped below detectable levels in this strain, demonstrating that, as expected, Kex2-dependent cleavage is primarily responsible for liberation of Pla from these fusion proteins. Since cellassociated 1la activities produced by BFY113 transformants containing these fusions were also decreased by 70 to 80%o, these cell-associated activities probably also reflect Kex2-processed ,la rather than unprocessed, membrane-bound fusion protein. The time required for Pla to reach the medium in cells expressing p2OSPB is fairly long (about 20 min at 30°C), and a significant fraction of the cell-associated activity is associated with the cell walls (10) . This may explain why the fraction of processed ,la remaining cell associated increases at lower expression levels ( Table 1) . Cotransforming BFY113 with Ste2-98-PxB and pKEX2-H elevated the level of activity to that observed in transformants of strain DJ213-7-3 ( Table 1) , showing that the difference in ila activity observed between BFY113 and DJ213-7-3 is due to KEX2 activity. With the exception of the activity of the Ste2-235-PxB fusion, levels of cell-associated activity of the presumptively cytoplasmic fusions were unaffected by the kex2 mutation (Table 1) . Since the Ste2-44-PxB fusion is apparently cytoplasmic and the Ste2-369-PxB fusion is correctly folded (see below), it was not surprising that their expression levels were unaffected. Perhaps a small fraction of the cell-associated Pla activity of the Ste2-235-PxB fusion results from improper membrane insertion events leading to Ste2-1la molecules that can be cleaved by Kex2. If so, total Pla activity could be enhanced by the stp22 mutation, while the level secreted would still be too low to be detectable in culture supernatants.
Receptor activity of fusion proteins. All transformants containing Ste2-PxB fusion constructs have a ste2 background and were tested for expression of functional Ste2 derived from the plasmids by use of the zone assay for a-factor sensitivity (24) . Activity was detected only for Ste2-369-PxB. Assuming the specific activity of the Pla component of the fusion protein to be equal to that of free Pla, the expression level of Ste2-369-PxB in strain DJ240-8-3 (stp22-7) is 2,000 to 3,000 cell-1, approximately 20 to 30% of the wild-type level of Ste2 (25) . As expected if a receptor of normal function were expressed at this reduced level, these transformants gave a near-normal response to a-factor, as judged by zone size and clarity (Fig. 4) . Use of heavier inocula produced turbid zones, indicating a response weaker than that of wild type (not shown). DJ213-7-3 (STP22) transformants containing the Ste2-369-PxB fusion gave no response to a-factor, presumably reflecting the threefoldlower expression level of the Ste2-369-PxB fusion protein seen in this strain.
Immunoblotting of Ste2-PxB fusion proteins. Since cell extracts obtained from Ste2-44-PxB and Ste2-369-PxB transformants contained Ila activities that were not affected by a kex2-null mutation, it was anticipated that these activities would reflect the activities of intact fusion proteins. The content and gel mobility of Ste2-P-Pla proteins present in transformants containing these plasmids were therefore determined by immunoblotting. The predominant immunoreactive species in transformants containing Ste2-369-PxB was an approximately 80-kDa protein corresponding to the SC-Ura agar (5 ml) was seeded with 2 x 10' organisms and poured onto an SC-Ura plate, and sterile disks containing 8.5, 2.1, 0.5, or 0.1 ,ug of synthetic a-factor (counterclockwise from the top) were placed on top of the overlay. Plates were incubated for 48 h at 30°C. expected size of the unprocessed Ste2-369-PxB fusion protein (Fig. 5, lane 2) . The observed receptor function of this fusion protein indicates that it is correctly inserted into and folded within the ER membrane and is subsequently localized to the plasma membrane. Some smaller-sized species were also present in Ste2-369-PxB-containing extracts, including a species with approximately the same mobility as mature-length ,-lactamase (29 kDa). These lower-molecularmass species probably arise as a result of proteolysis occurring during secretion, turnover, or cell lysis. The predominance of the mature-length P-lactamase species probably indicates that this fragment of the fusion protein, like P-lactamase itself, is relatively resistant to further degradation. The amount of Ste2-369-PxB fusion protein present in cell extracts, estimated from the strength of the Western blot signal (Fig. 5 ), correlated well with that predicted from jla (Table 1 ). This implies that the cytoplasmically located ala, tethered to the membrane at the C terminus of Ste2, retains full activity in yeast cells, a finding that concurs with previous reports on expression of ,-lactamasecontaining fusion proteins in E. coli (8) .
Extracts from transformants expressing Ste2-44-PxB did contain a minor immunoreactive species of approximately 40 kDa, the expected size of this fusion protein. However, the majority of immunoreactive material in these transformants appeared to be mature-length 29-kDa 13la (Fig. 5, lane 3) . Since this apparent processing is not Kex2 dependent, it is presumably occurring nonspecifically, before or after cell breakage. The rather low activities observed suggested that the Ste2 N-terminal fragment targets this fusion protein for destruction by cytoplasmic surveillance mechanisms (4, 21 (Fig. 2G) . In theory, if the preceding Ste2 sequence dictates that the site of fusion is cytoplasmic, as for the Ste2-235-SPB fusion (Fig. 3D) , the S signal peptide should act as an internal signal, leading to exposure of the PB reporter on the lumenal face of the secretory pathway. In Ste2-235-SPB and Ste2-369-SPB, the introduction of S resulted in secretion of amounts of Pla by transformants of strain DJ213-7-3 (STP22) or DJ240-8-3 (stp22) comparable to or higher than those obtained with transformants possessing Ste2-98-PxB, Ste2-206-PxB, or Ste2-259-PxB (Tables 1 and 2 ). Insertion of the signal sequence, therefore, apparently led to reorientation of the P-,la component of the resultant fusions from the cytoplasmic to the external compartment, as predicted. 13la activities produced by the Ste2-SPB fusions did not appear to be positively affected by the stp22-7 mutation, suggesting that addition of the yeast killer toxin signal might improve the efficiency of membrane insertion of fusions containing less than the full complement of Ste2 membrane-spanning segments. When the same signal sequence was placed between the Ste2 and P components of Ste2-98-PxB, the most effi-ciently expressed periplasmic fusion, secretion of fila decreased by 60 to 70%. Reorientation of the PB reporter to the cytoplasm may have occurred (Fig. 3B) . DISCUSSION This study describes the first demonstration of a gene fusion approach to in vivo analysis of plasma membrane protein topology in S. cerevisiae. While analysis of expression of direct fusions between Ste2 and Pla was largely fruitless, apparently because of efficient destruction of the fusion products, the introduction of a Kex2-cleavable bridge (P) between the target protein and the reporter resulted in accumulation of secreted pla from those fusions in which the Ppla reporter is lumenal and therefore exposed to the active site of Kex2 during passage through the Golgi. Although this accumulated activity probably still represented only a few percent of the total products of translation, 1la was released at reproducible and readily assayable levels. Analysis of these enzyme activities provided clear-cut, positive evidence of the lumenal location of target reporter fusion sites in all three Ste2 loops predicted to be external (fusions at 98, 206, and 259) and gave negative evidence for the location of the two fusions sites at 235 and 369, predicted to be in cytoplasmic domains.
In interpreting all such fusion experiments, the uncertainty principle must be kept in mind: experimental observation inevitably perturbs the system observed. In gene fusions, the reporter clearly has the potential to affect membrane insertion of the attached target. Nevertheless, our data suggest that the PxB reporter is relatively neutral in its effects. It should be noted, however, that PxB fusions introduce a short, hydrophobic, and potentially a-helical stretch at the N terminus of P that consists of one to four Ala residues derived from the PstI linkers followed by Ile Leu (Fig. 1) . The Phe-98 (DraI) and Ser-259 (ClaI) fusion sites occur three and seven residues, respectively, before the predicted C termini of transmembrane segments (Fig. 1) . The fusion replaces those residues with Ala Ala Ala Ile Leu, potentially contributing to the fidelity of membrane insertion of the products.
Use of the SP bridge, predicted to result in translocation of the PB reporter from cytoplasmic sites of fusion to the lumen, allowed positive identification of the cytoplasmic fusion sites at 235 and 369. Secreted P-lactamase activities were as high as with any of the lumenal PxB fusions lacking the S signal. The marked reduction in secreted ,la observed on insertion of S into the Ste2-98-PxB fusion was consistent with the lumenal location of this fusion site indicated by the PxB fusion data: the killer toxin signal, when preceded by another signal sequence such as the second membranespanning segment of Ste2, may function as a stop-transfer sequence and thus reorient the P-1la reporter to the cytoplasm (Fig. 3B) . Such interconversion of signal and stoptransfer functions is sometimes inefficient (13) , possibly because of the more-stringent demands for hydrophobicity postulated for stop-transfer segments and possibly because of the dominant role normally played by flanking positive charges in determining topogenicity (7, 37) . S is reasonably hydrophobic and does have two positively charged residues near its N terminus but none at its C terminus, where they might enhance its function as a stop-transfer sequence. It is, therefore, probably much more efficient as a signal. An alternative explanation of the effect of insertion of S on expression of the Ste2-98-SPB fusion is that the two additional positively charged residues introduced into the first extracellular loop of Ste2 (Fig. 1) (Fig. 2B ), it appears that these Ste2 fragments are responsible for loss of most of the translation product prior to the point in the secretory pathway at which Kex2 cleavage occurs. Destruction presumably results from action of the salvage pathway and ER-associated degradation pathways (2, 5, 30, 38) , which appear to be efficient in recognizing truncated Ste2 fragments. Only fusion Ste2-369-PxB, in which only 63 amino acids were removed from the C terminus of Ste2, appeared to be relatively stable as a membrane-bound fusion protein. An equivalent C-terminal deletion of Ste2 is stable and functional when expressed from a YEp plasmid (25) .
Several features of the killer toxin-,B-lactamase gene fusion approach contribute to overcoming the problem of in vivo fusion protein instability. First, the Kex2-mediated liberation of the Pla reporter avoids destruction of fusion proteins in the vacuole due to missorting or endocytosis. Second, the stability of secreted Pla allows accumulation of sufficient enzyme for detection. Third, the sensitivity of the P-lactamase activity assay (10) 
